Page last updated: 2024-08-25

budipine and selegiline

budipine has been researched along with selegiline in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mihatsch, W; Przuntek, H; Russ, H1
Ghaemi, M; Rudolf, J; Schmülling, S1
Ludolph, A; Odin, P; Oehlwein, C; Polzer, U; Renner, R; Schüler, P; Shing, M; Storch, A; Werner, G1
Büttner, T; Csoti, I; Kassubek, J; Reichmann, H; Riederer, P; Schulz, JB; Wüllner, U1

Reviews

1 review(s) available for budipine and selegiline

ArticleYear
[On the role of MAO B inhibitors and NMDA antagonists in the therapy of Parkinson's disease].
    Fortschritte der Neurologie-Psychiatrie, 2010, Volume: 78 Suppl 1

    Topics: Amantadine; Excitatory Amino Acid Antagonists; Humans; Indans; Memantine; Monoamine Oxidase; Monoamine Oxidase Inhibitors; N-Methylaspartate; Parkinson Disease; Piperidines; Selegiline

2010

Trials

1 trial(s) available for budipine and selegiline

ArticleYear
Efficacy and safety of high-dose cabergoline in Parkinson's disease.
    Acta neurologica Scandinavica, 2006, Volume: 113, Issue:1

    Topics: Adolescent; Adult; Aged; Amantadine; Antiparkinson Agents; Cabergoline; Catechols; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Ergolines; Humans; Levodopa; Middle Aged; Nitriles; Parkinson Disease; Piperidines; Prospective Studies; Quality of Life; Selegiline; Severity of Illness Index; Treatment Outcome

2006

Other Studies

2 other study(ies) available for budipine and selegiline

ArticleYear
Intracerebroventricular administration of 1-methyl-4-phenylpyridinium ion in mice: effects of simultaneously administered nomifensine, deprenyl, and 1-t-butyl-4,4-diphenylpiperidine.
    Journal of neural transmission, 1988, Volume: 71, Issue:3

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Brain; Catecholamines; Caudate Nucleus; Dose-Response Relationship, Drug; Drug Interactions; Female; Injections, Intraventricular; Male; Monoamine Oxidase Inhibitors; Movement Disorders; Nomifensine; Phenethylamines; Piperidines; Pyridinium Compounds; Selegiline; Serotonin

1988
Deterioration of parkinsonian symptoms following treatment of dopaminergic hallucinosis with olanzapine.
    European psychiatry : the journal of the Association of European Psychiatrists, 1999, Volume: 14, Issue:6

    Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Drug Therapy, Combination; Hallucinations; Humans; Levodopa; Male; Olanzapine; Paranoid Disorders; Parkinson Disease; Piperidines; Pirenzepine; Selegiline; Severity of Illness Index

1999
chemdatabank.com